-
(6th CIIE) Foreign Enterprise Discussion on CIIE: CIIE demonstrates its "win-win" value in promoting global rare disease diagnosis and treatment
After AstraZeneca acquired rare disease innovative drug company Ruisong Pharmaceuticals at the end of 2020, it immediately decided to bring all its innovative products into China. Our first rare dise ...